Relationship between Bone Histology and Markers of Bone and Mineral Metabolism in African-American Hemodialysis Patients
Open Access
- 1 September 2009
- journal article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 4 (9) , 1484-1493
Abstract
Background and objectives: Racial differences in mineral metabolism exist in the chronic kidney disease population, especially as it relates to intact parathyroid hormone (iPTH) levels. Few data exist on the relationship of these markers to bone biopsy findings in African-American (AA) hemodialysis patients across the spectrum of renal osteodystrophy (ROD). Design, setting, participants, & measurements: In prevalent AA hemodialysis subjects, we prospectively evaluated subjects by performing transiliac bone biopsy and correlating biochemical and clinical data to bone histology. Results: Study patients (n = 43) had an average age of 53.7 (±11.6) yr, with dialysis vintage of 40.4 (±24.5) mo, 30% with diabetes, and 51% male. Bone histology revealed adynamic bone disease (ABD) (16%), mild to moderate hyperparathyroidism (HPT) (72%), severe (12%) HPT, and no osteomalacia or mixed uremic osteodystrophy. At the time of biopsy, mean corrected calcium was 9.1, 8.9, and 9.4 mg/dl (P = 0.344); calcium-phosphorus (Ca × PO4) product was 42, 55, and 62 mg2/dl2 (P = 0.002); phosphorus was 4.6, 6.2, and 6.7 mg/dl (P = 0.005); and iPTH was 225, 566, and 975 pg/ml (P = 0.006), respectively. Median values for bone-specific alkaline phosphatase (BS-AP) were 16, 34, and 64 ng/ml (P < 0.0001) among the three groups. Conclusions: These data demonstrate that across the spectrum of ROD, iPTH levels are higher than expected in AA hemodialysis subjects. iPTH, PTH peptides, and bone-specific alkaline phosphatase correlated directly with histomorphometric measurements of bone turnover and when subjects were grouped by histologic diagnosis. Only 9.5% of subjects were simultaneously within suggested Kidney Disease Outcomes Quality Initiative (K/DOQI) ranges for Ca × PO4, phosphorus, and iPTH, of which 75% demonstrated ABD on biopsy.Keywords
This publication has 35 references indexed in Scilit:
- Effects of Treatment of Renal Osteodystrophy on Bone HistologyClinical Journal of the American Society of Nephrology, 2008
- Effects of Sevelamer Hydrochloride and Calcium Carbonate on Renal Osteodystrophy in Hemodialysis PatientsJournal of the American Society of Nephrology, 2008
- Adynamic bone disease and malnutrition–inflammation–cachexia syndromeKidney International, 2007
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006
- Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal diseaseKidney International, 2003
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal DiseaseHypertension, 2001
- Differences in calcium absorption and kinetics between black and white girls aged 5–16 yearsJournal of Bone and Mineral Research, 1995
- Diminished Rates of Bone Formation in Normal Black AdultsNew England Journal of Medicine, 1988
- Detection and distribution of aluminium in bone.Journal of Clinical Pathology, 1984
- A program package for quantitative analysis of histologic structure and remodeling dynamics of boneComputer Programs in Biomedicine, 1981